ADOPTING SGLT2 INHIBITORS WITHIN A RESIDENT-RUN URBAN MEDICINE CLINIC: AN INTERDISCIPLINARY APPROACH

被引:0
|
作者
Neumann, Melissa [1 ]
Smith, Alexander T. [1 ]
Syed, Noreen [1 ]
Ehrlch, Jason [2 ]
机构
[1] Donald & Barbara Zucker Sch Med Hofstra Northwell, Internal Med, Hempstead, NY USA
[2] Northwell Hlth, Med, New Hyde Pk, NY USA
关键词
D O I
暂无
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
引用
收藏
页码:S685 / S685
页数:1
相关论文
共 37 条
  • [31] Exploring sodium glucose cotransporter (SGLT2) inhibitors with machine learning approach: A novel hope in anti-diabetes drug discovery
    Moinul, Md
    Amin, Sk Abdul
    Kumar, Prabhat
    Patil, Umesh Kumar
    Gajbhiye, Asmita
    Jha, Tarun
    Gayen, Shovanlal
    JOURNAL OF MOLECULAR GRAPHICS & MODELLING, 2022, 111
  • [32] Identifying Patients at Risk of Acute Kidney Injury Among Medicare Beneficiaries With Type 2 Diabetes Initiating SGLT2 Inhibitors: A Machine Learning Approach
    Yang, Lanting
    Gabriel, Nico
    Hernandez, Inmaculada
    Vouri, Scott M.
    Kimmel, Stephen E.
    Bian, Jiang
    Guo, Jingchuan
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [33] Differences in Heart Failure Hospitalization Risk following Initiating SGLT2 Inhibitors vs. DPP4 Inhibitors across Race/Ethnicity and Rural/Urban Areas
    Guo, Jingchuan
    Li, Yujia
    Bian, Jiang
    Lackland, Daniel T.
    Kimmel, Stephen
    Schatz, Desmond
    Winterstein, Almut G.
    DIABETES, 2022, 71
  • [34] Precision medicine in type 2 diabetes: harnessing individual-level trial data alongside routine care records to identify predictors of response to SGLT2 inhibitors and DPP4 inhibitors
    Dennis, J. M.
    Henley, W.
    Jones, A.
    McGovern, A.
    Pearson, E.
    Hattersley, A.
    Shields, B.
    DIABETOLOGIA, 2019, 62 : S178 - S178
  • [35] Clinical and biochemical outcomes of Sodium-Glucose CoTransporter-2 (SGLT2) Inhibitors in Type-2 Diabetes Mellitus Patients as a fourth oral anti diabetic medicine
    Saleem, Muhammad
    Khan, Sajjad Ali
    Suchal, Zafar Aleem
    Ram, Nanik
    PAKISTAN JOURNAL OF MEDICAL SCIENCES, 2022, 38 (05) : 1255 - 1259
  • [36] A Quality Improvement Project of Increasing Utilization of SGLT2i in Patients With Heart Failure Within a Veterans Affairs Health System Through an Interdisciplinary Approach in the Primary Care Setting
    Baviriseaty, Niharika
    Parza, Kevin
    Gross, Cassandra
    Nehaul, Roger
    CIRCULATION, 2023, 148
  • [37] Kidney and Metabolic Benefits by Adding GLP-1 Agonists and/or SGLT2 Inhibitors on Metformin in Obese Type 2 Diabetes (T2DM) Patients: 24-Month Real-World Data from Both Urban and Rural Clinics
    Zoupas, Ioannis
    Papazafiropoulou, Athanasia
    Xenou, Maria
    Lygnos, Dimitrios
    Fousteris, Evangelos
    DIABETES, 2021, 70